Resnick L M, Barbagallo M, Dominguez L J, Veniero J M, Nicholson J P, Gupta R K
Hypertension Center, New York Presbyterian Hospital-Cornell Medical Center, New York, New York, USA.
Hypertension. 2001 Sep;38(3 Pt 2):709-12. doi: 10.1161/01.hyp.38.3.709.
To investigate the role of intracellular potassium (K(i))and other ions in hypertension and diabetes, we utilized (39)K-, (23)Na-, (31)P-, and (19)F-nuclear magnetic resonance (NMR) spectroscopy to measure K(i), intracellular sodium (Na(i)), intracellular free magnesium (Mg(i)), and cytosolic free calcium (Ca(i)), respectively, in red blood cells of fasting normotensive nondiabetic control subjects (n=10), untreated (n=13) and treated (n=14) essential hypertensive subjects, and diabetic subjects (n=5). In 12 subjects (6 hypertensive and 6 normotensive controls), ions were also measured before and after the acute infusion of 1 L of normal saline. Compared with those in controls (K(i)=148+/-2.0 mmol/L), K(i) levels were significantly lower in hypertensive (132.2+/-2.9 mmol/L, sig=0.05) and in type 2 diabetic subjects (121.2+/-6.8 mmol/L, sig=0.05). K(i) was higher in treated hypertensives than in untreated hypertensives (139+/-3.1 mmol/L, sig=0.05) but was still lower than in normals. Although no significant relation was observed between basal K(i) and Na(i) values, saline infusion elevated Na(i) (P<0.01) and reciprocally suppressed K(i) levels (142+/-2.4 to 131+/-2.2 mmol/L, P<0.01). K(i) was strongly and inversely related to Ca(i) (r=-0.846, P<0.001), and was directly related to Mg(i) (r=0.664, P<0.001). We conclude that (1) K(i) depletion is a common feature of essential hypertension and type 2 diabetes, (2) treatment of hypertension at least partially restores K(i) levels toward normal, and (3) fasting steady-state K(i) levels are closely linked to Ca(i) and Mg(i) homeostasis. Altogether, these results emphasize the similar and coordinate nature of ionic defects in diabetes and hypertension and suggest that their interpretation requires an understanding of their interaction.
为研究细胞内钾(K(i))及其他离子在高血压和糖尿病中的作用,我们利用(39)K、(23)Na、(31)P和(19)F核磁共振(NMR)波谱技术,分别测定了空腹血压正常的非糖尿病对照受试者(n = 10)、未经治疗(n = 13)和经治疗(n = 14)的原发性高血压受试者以及糖尿病受试者(n = 5)红细胞内的K(i)、细胞内钠(Na(i))、细胞内游离镁(Mg(i))和胞质游离钙(Ca(i))。在12名受试者(6名高血压患者和6名血压正常的对照者)中,还在静脉快速输注1升生理盐水前后测定了离子水平。与对照组(K(i)=148±2.0 mmol/L)相比,高血压患者(132.2±2.9 mmol/L,P = 0.05)和2型糖尿病患者(121.2±6.8 mmol/L,P = 0.05)的K(i)水平显著降低。经治疗的高血压患者的K(i)水平高于未经治疗的高血压患者(139±3.1 mmol/L,P = 0.05),但仍低于正常水平。尽管基础K(i)和Na(i)值之间未观察到显著相关性,但生理盐水输注使Na(i)升高(P<0.01),并相应地抑制了K(i)水平(从142±2.4 mmol/L降至131±2.2 mmol/L,P<0.01)。K(i)与Ca(i)呈强烈负相关(r = -0.846,P<0.001),与Mg(i)呈正相关(r = 0.664,P<0.001)。我们得出以下结论:(1)K(i)缺乏是原发性高血压和2型糖尿病的共同特征;(2)高血压治疗至少可部分使K(i)水平恢复正常;(3)空腹稳态K(i)水平与Ca(i)和Mg(i)的稳态密切相关。总之,这些结果强调了糖尿病和高血压中离子缺陷的相似性和协同性,并表明对它们的解释需要了解它们之间的相互作用。